Flumazenil is a competitive GABAA receptor antagonist, used in the treatment of benzodiazepine overdoses.
Molecular Weight | 303.29 |
Formula | C15H14FN3O3 |
CAS Number | 78755-81-4 |
Solubility (25°C) | 10 mM in DMSO |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Related GABA Receptor Products |
---|
Cenobamate
Cenobamate (YKP-3089) is a novel antiepileptic agent with broad-spectrum anticonvulsant activity. |
Afizagabar
Afizagabar (S44819) is a first-in-class, competitive and selective α5-GABAAR antagonist with an IC50 value of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. |
Pentetrazol (98%)
Pentetrazol (PTZ), a tetrazole derivative, is an inhibitor of gamma aminobutyric acid (GABAA) and its receptor complex. PTZ is a convulsive agent used to induce convulsions. It can penetrate the blood-brain barrier. |
L-DAB HBR
L-DAB HBR (L-Dab Hydrobromide, L-2,4-Diaminobutyric acid hydrobromide) is an inhibitor of GABA (Gamma-aminobutyric acid) transaminase with IC50 of >500 μM. L-DAB HBR exhibits antitumor activity. |
Phenibut
Phenibut, a GABA analogue, is a central nervous system depressant with anxiolytic and sedative effects. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.